Medicine and Dentistry
Breast Cancer
100%
Ovarian Cancer
49%
BRCA1
41%
Neoplasm
31%
Letrozole
22%
Pre-Eclampsia
22%
Human Umbilical Vein Endothelial Cell
22%
Pelvic Floor
22%
Dual-Energy X-Ray Absorptiometry
22%
Vimentin
22%
Uvomorulin
22%
Protein P53
22%
Fallopian Tube Mucosa
22%
Cancer Risk
22%
Case-Control Study
22%
Death Receptor 4
22%
Mesenchymal-Epithelial Transition
22%
Fulvestrant
22%
Palbociclib
22%
Ovary Adenocarcinoma
22%
Surgery
18%
Antiangiogenic Activity
16%
Cell Proliferation Assay
16%
Enzyme Linked Immunosorbent Assay
16%
CDK4/6 Inhibitor
16%
Hormone Receptor
15%
Cancer
14%
Metastatic Carcinoma
14%
Disease Free Survival
13%
Survival Rate
13%
Diseases
11%
Quantitative Assay
11%
Monoclonal Antibody
11%
Surgeon
11%
Surgical Technique
11%
Fallopian Tube
9%
Chemotherapy
9%
Overall Survival
8%
Aromatase Inhibitor
8%
Hormone Therapy
8%
Lymph Node
7%
Introitus
7%
Intraductal Carcinoma
7%
Cancer Grading
7%
Lymphovascular Invasion
7%
Invasive Carcinoma
7%
Testis Determining Factor
7%
Transcription Factors
7%
Perineum
7%
Metastasis Potential
7%
Serous Carcinoma
7%
Factor XI
7%
Programmed Cell Death
7%
Krukenberg Tumor
7%
BRCA2
7%
Subgroup Analysis
6%
Malignant Neoplasm
6%
Estrogen Receptor Positive Breast Cancer
6%
Adjuvant Chemotherapy
6%
Retinopathy
5%
Prolactin
5%
Gestational Hypertension
5%
Cell Proliferation
5%
Antiangiogenic
5%
Angiogenesis Assay
5%
Biological Marker
5%
Biological Activity
5%
Peripartum Cardiomyopathy
5%
Exemestane
5%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
62%
Ovary Cancer
44%
Preeclampsia
22%
Antiangiogenic
22%
Endocrine Therapy
22%
Letrozole
22%
Uvomorulin
22%
Vimentin
22%
Hormone Receptor
22%
Death Receptor 4
22%
Fulvestrant
22%
Palbociclib
22%
Retrospective Study
22%
Jaw Osteonecrosis
22%
Metastasis
19%
Enzyme-Linked Immunosorbent Assay
16%
Denosumab
14%
Monoclonal Antibody
11%
Disease Free Survival
11%
Carcinoma
7%
Transcription Factors
7%
Testis Determining Factor
7%
Metastasis Potential
7%
Ovary Carcinoma
7%
Blood Clotting Factor 11
7%
Bisphosphonic Acid Derivative
7%
Bone Metastasis
7%
Chick
5%
Prolactin
5%
Retinopathy
5%
Peripartum Cardiomyopathy
5%
Maternal Hypertension
5%
Recurrence Risk
5%
Survival Rate
5%
Clinical Trial
5%
Biological Marker
5%
Overall Survival
5%
Exemestane
5%
Anastrozole
5%